Congenica is a biotechnology company that provides a diagnostic decision support platform.
Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients.It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 9, 2020 | Series C | $50M | 1 | — | — | Detail |
Apr 30, 2019 | Series B | £13.50M | 1 | — | — | Detail |
Apr 27, 2017 | Series B | — | 1 | — | — | Detail |
Feb 27, 2017 | Series B | £8M | 1 | — | — | Detail |
Apr 14, 2015 | Series A | £2.20M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cambridge Innovation Capital | — | Series C |
Digital China Health Technologies Corporation (DCHealth) | — | Series B |
Healthlink Capital | — | Series B |